Zobrazeno 1 - 10
of 504
pro vyhledávání: '"H.-J. Kolb"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D. Fischbacher, Christine Grabrucker, D. Kraemer, Amy E. Liepert, H. J. Kolb, J. Dreyssig, Arndt Borkhardt, C.-H. Koehne, M. Freudenreich, F. Schuster, M. Merle, Andreas Kremser, Tanja Kroell, Christoph Schmid, H. M. Schmetzer
Publikováno v:
Immunol. Invest. 49, 365-385 (2019)
In cancer or hematologic disorders, chemokines act as growth- or survival factors, regulating hematopoiesis and angiogenesis, determining metastatic spread and controlling leukocyte infiltration into tumors to inhibit antitumor immune responses. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0174907d683d95fddf376ef574fdb88f
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=56941
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=56941
Autor:
Rainer Burgkart, Katharina Götze, Ulrike Höckendorf, Jürgen Ruland, Veronika Reidel, Oliver Gorka, Christian Peschel, Christina Huberle, Burkhard Schmidt, Philipp J. Jost, Robert A.J. Oostendorp, H-J Kolb, J. König, Johannes Schauwecker, Stefanie Jilg, Catharina Müller-Thomas
Publikováno v:
Leukemia. 30:112-123
Deregulated apoptosis is an identifying feature of myelodysplastic syndromes (MDS). Whereas apoptosis is increased in the bone marrow (BM) of low-risk MDS patients, progression to high-risk MDS correlates with an acquired resistance to apoptosis and
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 110:908-914
In a controlled clinical trial, the efficacy of an intravenous combination of cimetidine and pirenzepine (group A: 62 patients) was compared with that of an intragastric administration of a magnesium-aluminium-hydroxide concentrate (group B: 58 patie
Autor:
C. Kyriakou, C. Canals, A. Goldstone, D. Caballero, B. Metzner, G. Kobbe, H.-J. Kolb, J. Kienast, P. Reimer, J. Finke, G. Oberg, A. Hunter, N. Theorin, A. Sureda, N. Schmitz
Publikováno v:
Journal of Clinical Oncology. 26:218-224
Autor:
Detlef Haase, Hans-Peter Horny, Otto Krieger, Arjan A. van de Loosdrecht, Wolfgang R. Sperr, Denise A. Wells, Reinhard Stauder, Michael R. Loken, Christa Fonatsch, Ulrich Germing, Peter L. Greenberg, Peter Valent, Björn Rüter, Michael Pfeilstöcker, Torsten Haferlach, Alberto Orfao, Kiyoyuki Ogata, H. J. Kolb, John M. Bennett
Publikováno v:
Leukemia Research. 31:727-736
The classification, scoring systems, and response criteria for myelodysplastic syndromes (MDS) have recently been updated and have become widely accepted. In addition, several new effective targeted drugs for patients with MDS have been developed. Th
Autor:
O. Maywald, Tobler A, L. Breitscheidel, Markus Pfirrmann, Andreas Reiter, S. U. Gnad, Ruediger Hehlmann, Georgia Metzgeroth, H. J. Kolb, Dietrich W. Beelen, Alois Gratwohl, Andreas Hochhaus, Ursula Berger, Joerg Hasford
Publikováno v:
Leukemia. 20:477-484
We investigated the impact of a cytogenetic response (CyR) to IFN prior to and at the time of allogeneic hematopoietic stem cell transplantation (HSCT) on transplant-related mortality (TRM), relapse rate and survival probability after HSCT in 162 tra
Autor:
Petr Sedlacek, Eliane Gluckman, Udo Holtick, Yesilda Balavarca, Hildegard Greinix, Heike Bickeböller, Kim F. Pearce, Ralf Dressel, Jean Norden, Graham Jackson, Daniel Wolff, H-J Kolb, Antoine Toubert, Gérard Socié, Ernst Holler, Anne M. Dickinson, Ilona Hromadnikova, Matthew Collin, V. Rocha
Publikováno v:
Bone marrow transplantation. 50(11)
Previous studies of non-histocompatibility leukocyte antigen (HLA) gene single-nucleotide polymorphisms (SNPs) on subgroups of patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) revealed an association with transplant outc
Autor:
Holger Hebart, Georg Maschmeyer, Hans Martin, Volker Runde, Ulrike Schumacher, Joachim Kienast, Ernst Holler, Helmut Oettle, Hartmut Link, Jörg Beyer, Michael G. Kiehl, Dietger Niederwieser, Thomas Klingebiel, Christian Schmidt, Rainer Schwerdfeger, Hermann Einsele, Robert Beck, Andrew J. Ullmann, Hartmut Bertz, William Krüger, H. J. Kolb
Publikováno v:
Annals of Hematology
The risk of infection after allogeneic stem cell transplantation is determined by the underlying disease, the intensity of previous treatments and complications that may have occurred during that time, but above all, the risk of infection is determin